newsfilter
← Latest News
GlobeNewswire·

Prelude Therapeutics to Participate in Upcoming Healthcare Conferences

WILMINGTON, Del., June 03, 2024 (GLOBE NEWSWIRE) -- Prelude Therapeutics Incorporated (NASDAQ:PRLD), a clinical-stage precision oncology company, announced today that the Company will participate in two upcoming